Clinical Trial Update: Effect of Empagliflozin on Liver Fat in Non-diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial updating the effects of empagliflozin on liver fat in non-diabetic patients with non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: The University of Hong Kong | Conditions: Non-alcoholic Fatty Liver Disease | Phase 4 | Status: COMPLETED